Patents for C07K 19 - Hybrid peptides (29,428) |
---|
10/12/2000 | WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
10/12/2000 | WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
10/12/2000 | WO2000060066A1 Protein-protein from s. cerevisiae and methods of using same |
10/12/2000 | WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof |
10/12/2000 | WO2000059535A2 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
10/12/2000 | WO2000036129A8 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
10/12/2000 | WO2000020449A3 MODIFIED TGF-β SUPERFAMILY PROTEINS |
10/12/2000 | WO2000020446A3 Bax-mediated apoptosis modulating reagents and methods |
10/12/2000 | WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
10/12/2000 | CA2368183A1 Supar stimulating activity of tcupa-mediated fibrinolysis and different uses thereof |
10/12/2000 | CA2365548A1 Protein-protein from s. cerevisiae and methods of using same |
10/12/2000 | CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
10/12/2000 | CA2365040A1 Hob-bp2h compositions, methods and uses thereof |
10/11/2000 | EP1042491A1 Maize h3c4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
10/11/2000 | EP1042480A1 Streptococcal heat shock proteins of the hsp60 family |
10/11/2000 | EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
10/11/2000 | EP1042467A1 Non-identical genes and their application in improved molecular adjuvants |
10/11/2000 | EP1042465A1 Human thyroid protein zsig45 and dna encoding same |
10/11/2000 | EP1042459A1 Bifunctional molecules |
10/10/2000 | US6130313 Rapidly degrading GFP-fusion proteins |
10/10/2000 | US6130203 Blood coagulation proteins with modified activities, such as enhanced coagulation activities. |
10/10/2000 | US6130085 Expression plasmid for the cloning, expression, and exposure of a heterologous polypeptide on the surface of the external membrane of a gram-negative bacteria; for production of antibodies against bacterial parasites |
10/10/2000 | CA2196797C In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
10/10/2000 | CA2195625C Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
10/05/2000 | WO2000058466A2 Protease resistant flint analogs |
10/05/2000 | WO2000058465A2 Flint polypeptide analogs |
10/05/2000 | WO2000058342A1 Process for partitioning of proteins |
10/05/2000 | WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity |
10/05/2000 | WO2000028039A3 Identification of senv genotypes |
10/05/2000 | WO2000027880A3 Rantes-derived peptides with anti-hiv activity |
10/05/2000 | WO2000022130A3 Metastatic breast and colon cancer regulated genes |
10/05/2000 | WO2000018881A9 Intein mediated peptide ligation |
10/05/2000 | WO2000011179A9 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM) |
10/05/2000 | CA2368760A1 Flint polypeptide analogs |
10/05/2000 | CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity |
10/05/2000 | CA2367826A1 Process for partitioning of proteins |
10/04/2000 | EP1041150A1 Hybrid synthetase, fungus/bacterium strain, hybrid peptide and compositions containing same |
10/04/2000 | EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease |
10/04/2000 | EP1040351A1 C-terminal region of agouti-related transcript (art) protein |
10/04/2000 | EP1040123A2 Human papillomavirus vaccine |
10/04/2000 | EP1039930A2 Adjuvanted vaccine formulation |
10/04/2000 | CN1268973A Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same |
10/04/2000 | CN1268377A Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action |
10/04/2000 | CN1057124C Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |
10/04/2000 | CN1057097C Chimeric proteins which block complement activation |
10/04/2000 | CN1057013C Novel 1 L-2 receptor-specific human immunoglobins |
10/03/2000 | US6127525 Coat protein having non-native, non-hexon amino acid sequence; allows decreased ability or inability to be recognized by neutralizing antibodies against wild-type protein; for gene therapy |
10/03/2000 | US6127169 Non-agglutinating β-galactoside binding protein and its encoding nucleic acid |
10/03/2000 | US6127162 Human prohormone convertase 4 |
10/03/2000 | US6127150 Vector for the efficient expression and isolation of heterologous proteins |
09/28/2000 | WO2000056896A1 Hybrid synthetase, hybrid peptide and composition containing same |
09/28/2000 | WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/28/2000 | WO2000056878A1 Methods of obtaining full-length nucleic acid sequences using e. coli topoisomerase iii and its homologs |
09/28/2000 | WO2000056764A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
09/28/2000 | WO2000029577A9 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
09/28/2000 | WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses |
09/28/2000 | CA2512479A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/28/2000 | CA2512291A1 Pro4356 polypeptides and nucleic acids encoding the same |
09/28/2000 | CA2510982A1 Lectin-like protein, pro1890, encoding nucleic acids, pro1890 antibodies and uses thereof |
09/28/2000 | CA2510931A1 Pro4334 polypeptides and nucleic acids |
09/28/2000 | CA2510806A1 Screted and transmembrane polypeptides and nucleic acids encoding the same |
09/28/2000 | CA2368548A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
09/28/2000 | CA2367723A1 Methods of obtaining full-length nucleic acid sequences using e. coli topoisomerase iii and its homologs |
09/28/2000 | CA2367475A1 Hybrid synthetase, hybrid peptide and composition containing same |
09/28/2000 | CA2361221A1 Novel protein which induces chondrocyte differentiation |
09/27/2000 | EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
09/27/2000 | EP1038000A1 Compounds and methods for the detection and prevention of (t. cruzi) infection |
09/27/2000 | EP1037995A1 Human interferon-epsilon: a type 1 interferon |
09/27/2000 | EP1037985A1 Restin and methods of use thereof |
09/27/2000 | EP1037984A1 Cadherin-like polypeptides, methods and compositions related thereto |
09/27/2000 | EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
09/27/2000 | EP1037979A2 Polypeptides and nucleic acids encoding the same |
09/27/2000 | EP1037969A1 Fibrinogen-converting enzyme hybrids |
09/27/2000 | EP1037927A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
09/27/2000 | EP1037911A1 Anti-pathogen system and methods of use thereof |
09/27/2000 | EP1037658A1 Ifnar2/ifn complex |
09/27/2000 | EP0805819A4 Chimeric dna-binding proteins |
09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
09/26/2000 | US6124117 Polysaccharide binding fusion proteins and conjugates |
09/26/2000 | US6123948 Antigenic determinants of atleast two human papilloma virus proteins selected from l1, l2, e1, e2, e3, e4, e5, e6, e7, in amorphous reaggregated form which when in solution can pass through a sterillization filter used as immunogenic |
09/21/2000 | WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection |
09/21/2000 | WO2000055194A2 Tuberculosis antigens and methods of use therefor |
09/21/2000 | WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
09/21/2000 | WO2000054789A1 Bacterial membrane fractions with adjuvant effect |
09/21/2000 | WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy |
09/21/2000 | WO2000040603A3 Production of recombinant monellin using methylotrophic yeast expression system |
09/21/2000 | WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000020574A3 Fusions of scaffold proteins with random peptide libraries |
09/21/2000 | DE19910419A1 Zielzellspezifische, multivalente Proteine (MVP) Target cell-specific, multivalent proteins (MVP) |
09/21/2000 | CA2367917A1 Bacterial membrane fractions with adjuvant effect |
09/21/2000 | CA2367906A1 Tcl-1b gene and protein and related methods and compositions |
09/20/2000 | EP1036185A1 Proteinase inhibitor fusion proteins |
09/20/2000 | EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy |
09/20/2000 | EP0672057B1 Analogs of pth |
09/20/2000 | EP0623216B1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS |
09/20/2000 | EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
09/19/2000 | US6121426 Fibrin binding domain polypeptides and uses and methods of producing same |